These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1740 related items for PubMed ID: 9632891

  • 1. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B.
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [Abstract] [Full Text] [Related]

  • 2. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 3. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L, Tian YJ, Shen H, Zhao XP, Yang DL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 26; 17(4):275-9. PubMed ID: 19403026
    [Abstract] [Full Text] [Related]

  • 4. Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.
    Torre F, Cramp M, Owsianka A, Dornan E, Marsden H, Carman W, Williams R, Naoumov NV.
    J Med Virol; 2004 Mar 26; 72(3):370-6. PubMed ID: 14748060
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative immunogenicity of hepatitis B virus core and E antigens.
    Milich DR, McLachlan A, Stahl S, Wingfield P, Thornton GB, Hughes JL, Jones JE.
    J Immunol; 1988 Nov 15; 141(10):3617-24. PubMed ID: 2460543
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
    Tindle RW, Herd K, Londoño P, Fernando GJ, Chatfield SN, Malcolm K, Dougan G.
    Virology; 1994 May 01; 200(2):547-57. PubMed ID: 7513919
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, Tyrrell DL, Samuel J.
    J Control Release; 2005 Jan 20; 102(1):85-99. PubMed ID: 15653136
    [Abstract] [Full Text] [Related]

  • 14. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S.
    Vaccine; 2011 Aug 26; 29(37):6342-51. PubMed ID: 21600951
    [Abstract] [Full Text] [Related]

  • 15. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF, Zhao HL, Xue C, Xiong XH, Zhang W, Yao XQ, Liu ZM.
    Vaccine; 2007 May 30; 25(22):4478-86. PubMed ID: 17467856
    [Abstract] [Full Text] [Related]

  • 16. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
    Takashima H, Araki K, Miyazaki J, Yamamura K, Kimoto M.
    Immunology; 1992 Mar 30; 75(3):398-405. PubMed ID: 1533387
    [Abstract] [Full Text] [Related]

  • 17. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
    Milich DR, Jones JE, Hughes JL, Maruyama T, Price J, Melhado I, Jirik F.
    J Immunol; 1994 Jan 15; 152(2):455-66. PubMed ID: 8283030
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F, Peterson D, Milich D.
    Intervirology; 1996 Jan 15; 39(1-2):104-10. PubMed ID: 8957676
    [Abstract] [Full Text] [Related]

  • 19. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
    Chen X, Lai J, Pan Q, Tang Z, Yu Y, Zang G.
    Vaccine; 2010 May 21; 28(23):3913-9. PubMed ID: 20394723
    [Abstract] [Full Text] [Related]

  • 20. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.
    Liver Transpl; 2008 Apr 21; 14(4):478-85. PubMed ID: 18324666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.